Stock Events

Stock Events

Emerald Health Therapeutics 

0
6
+C$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

31AugExpected
Q1 2021
Q2 2021
Q3 2021
Q2 2022
-0.07
-0.05
-0.03
-0.01
Expected EPS
N/A
Actual EPS
-0.0155

Financials

-404.66%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
9.68MRevenue
-39.17MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap449.07M
Canopy Growth Corporation is a leading cannabis company in Canada, directly competing in the same market as Emerald Health Therapeutics.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is another major player in the Canadian cannabis industry, offering similar products and competing for market share.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids, competing internationally with Emerald Health.
Cronos Group
CRON
Mkt Cap1.25B
Cronos Group is a globally diversified and vertically integrated cannabis company with a presence in five continents, directly competing with Emerald Health.
Organigram Global
OGI
Mkt Cap171.32M
Organigram Holdings Inc. is a leading licensed producer of cannabis products, competing in the Canadian market.
SNDL
SNDL
Mkt Cap336.94M
Sundial Growers is a Canadian cannabis producer, directly competing with Emerald Health in the cultivation and sale of cannabis products.
Village Farms International
VFF
Mkt Cap355.85M
Village Farms International, Inc. is involved in the production and sale of cannabis in Canada and the U.S., competing with Emerald Health.
Trulite
TRUL
Mkt Cap212,013
Trulieve Cannabis Corp. is a leading cannabis company in the United States with a growing presence in Canada, indirectly competing with Emerald Health.

About

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.
Show more...
CEO
Mr. Mohammed Jiwan
Country
Canada
ISIN
CA29102R1064
WKN
000A14VKJ

Listings

STU
DE
TBD.STU
CN
CA
EMH.CN

0 Comments

Share your thoughts

FAQ

What is Emerald Health Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Emerald Health Therapeutics stocks are traded under the ticker EMH.CN.
What were Emerald Health Therapeutics earnings last quarter?▼
EMH.CN earnings for the last quarter are -0.02 CAD per share, whereas the estimation was N/A CAD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A CAD per share.
What is Emerald Health Therapeutics revenue for the last year?▼
Emerald Health Therapeutics revenue for the last year amounts to 9.68M CAD.
What is Emerald Health Therapeutics net income for the last year?▼
EMH.CN net income for the last year is -39.17M CAD.
In which sector is Emerald Health Therapeutics located?▼
Emerald Health Therapeutics operates in the Health & Wellness sector.
When did Emerald Health Therapeutics complete a stock split?▼
The last stock split for Emerald Health Therapeutics was on January 28, 2013 with a ratio of 2:1.
Where is Emerald Health Therapeutics headquartered?▼
Emerald Health Therapeutics is headquartered in Vancouver, Canada.